Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-18-005919
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-29 17:43:43
Reporting Period:
2018-01-25
Accepted Time:
2018-01-29 17:43:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185039 Richard Aldrich C/o Concert Pharmaceuticals, Inc.
99 Hayden Avenue, Suite 500
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-25 5,000 $20.31 21,946 No 4 S Indirect See Footnote
Common Stock Disposition 2018-01-25 3,054 $20.22 44,351 No 4 S Indirect See Footnote
Common Stock Disposition 2018-01-26 5,000 $20.46 16,946 No 4 S Indirect See Footnote
Common Stock Disposition 2018-01-29 5,000 $21.36 11,946 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 286,975 Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017.
  2. The range of prices for the transaction reported on this line was $20.01 to $20.74. The average weighted price was $20.31. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc.
  4. The range of prices for the transaction reported on this line was $20.03 to $20.40. The average weighted price was $20.22. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  6. The range of prices for the transaction reported on this line was $20.34 to $20.67. The average weighted price was $20.46. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. The range of prices for the transaction reported on this line was $20.75 to $21.68. The average weighted price was $21.36. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.